{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:36:46Z","timestamp":1793371006778,"version":"4.5.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bulcan.2026.07.014","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:26:18Z","timestamp":1790627178000},"page":"1202-1210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Connaissances des m\u00e9decins g\u00e9n\u00e9ralistes sur les immunoth\u00e9rapies anticanc\u00e9reuses et leurs effets ind\u00e9sirables\u00a0: une enqu\u00eate transversale"],"prefix":"10.1016","volume":"113","author":[{"given":"Fran\u00e7ois","family":"Guigue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Pacoureau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"Placais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Coindard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lambotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bulcan.2026.07.014_bib0110","unstructured":"Panorama des cancers en France 2025, \u00e9dition sp\u00e9ciale 20\u00a0ans n.d. https:\/\/www.cancer.fr\/catalogue-des-publications\/panorama-des-cancers-en-france-2025-edition-speciale-20-ans. (accessed January 4, 2026)."},{"key":"10.1016\/j.bulcan.2026.07.014_bib0115","unstructured":"Cancer IND. Donn\u00e9es globales 2024. https:\/\/www.cancer.fr\/professionnels-de-sante\/statistiques-et-chiffres-sur-les-cancers\/epidemiologie-des-cancers\/donnees-globales (accessed February 11, 2026)."},{"key":"10.1016\/j.bulcan.2026.07.014_bib0120","unstructured":"SPF. Survie des personnes atteintes de cancer en France m\u00e9tropolitaine 1989-2018 - Synth\u00e8se des r\u00e9sultats\u00a0: tumeurs solides et h\u00e9mopathies malignes n.d. https:\/\/www.santepubliquefrance.fr\/import\/survie-des-personnes-atteintes-de-cancer-en-france-metropolitaine-1989-2018-synthese-des-resultats-tumeurs-solides-et-hemopathies-malignes (accessed January 4, 2026)."},{"key":"10.1016\/j.bulcan.2026.07.014_bib0125","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3109\/13814788.2015.1126821","article-title":"What role does the general practitioner in France play among cancer patients during the initial treatment phase with intravenous chemotherapy? A qualitative study","volume":"22","author":"Coindard","year":"2016","journal-title":"Eur J Gen Pract"},{"key":"10.1016\/j.bulcan.2026.07.014_bib0130","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/CCO.0000000000001113","article-title":"Long-term immune related adverse events","volume":"37","author":"Pla\u00e7ais","year":"2025","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.bulcan.2026.07.014_bib0135","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/fampra\/cmw034","article-title":"French general practitioners\u2019 sense of isolation in the management of elderly cancer patients","volume":"33","author":"Chicoulaa","year":"2016","journal-title":"Fam Pract"},{"key":"10.1016\/j.bulcan.2026.07.014_bib0140","article-title":"Keeping primary care \u201cin the loop\u201d: General practitioners want better communication with specialists and hospitals when caring for people diagnosed with cancer - Lizama","year":"2015","journal-title":"Asia-Pacific J Clin Oncol"},{"key":"10.1016\/j.bulcan.2026.07.014_bib0145","doi-asserted-by":"crossref","first-page":"2380722","DOI":"10.1080\/13814788.2024.2380722","article-title":"Multidisciplinary management of patients with cancer in France: the SINPATIC qualitative study","volume":"30","author":"Moscova","year":"2024","journal-title":"Eur J Gen Pract"},{"key":"10.1016\/j.bulcan.2026.07.014_bib0150","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1200\/JCO.2007.14.7710","article-title":"Tailored chemotherapy information faxed to general practitioners improves confidence in managing adverse effects and satisfaction with shared care: results from a randomized controlled trial","volume":"26","author":"Jefford","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2026.07.014_bib0155","first-page":"1015","article-title":"Information needs of oncologists, general practitioners and other professionals caring for patients with cancer","volume":"25","author":"Ciarlo","year":"2016","journal-title":"Eur J Cancer Care (Engl)"},{"key":"10.1016\/j.bulcan.2026.07.014_bib0160","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2524.2012.01075.x","article-title":"General Practitioners\u2019 perceptions of their role in cancer care and factors which influence this role","volume":"20","author":"Mitchell","year":"2012","journal-title":"Health Soc Care Community"},{"key":"10.1016\/j.bulcan.2026.07.014_bib0165","first-page":"137","article-title":"Communication between family physicians and oncologists: qualitative results of an exploratory study","volume":"3","author":"Dworkind","year":"1999","journal-title":"Cancer Prev Control"},{"key":"10.1016\/j.bulcan.2026.07.014_bib0170","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s11764-023-01486-y","article-title":"\u201cCare needs to be integrated\u201d patient and provider perspectives on a cancer shared-care model","volume":"19","author":"Adler Jaffe","year":"2025","journal-title":"J Cancer Surviv"},{"key":"10.1016\/j.bulcan.2026.07.014_bib0175","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejca.2015.11.016","article-title":"Immune-related adverse events with immune checkpoint blockade: a comprehensive review","volume":"54","author":"Michot","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bulcan.2026.07.014_bib0180","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1684\/bdc.2012.1574","article-title":"[The place of general practitioners in cancer care in Champagne-Ardenne]","volume":"99","author":"Tardieu","year":"2012","journal-title":"Bull Cancer"},{"key":"10.1016\/j.bulcan.2026.07.014_bib0185","first-page":"2473","article-title":"Primary care physicians and oncologists are partners in cancer announcement","volume":"24","author":"Roug\u00e9 Bugat","year":"2016","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.bulcan.2026.07.014_bib0190","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.4161\/hv.28943","article-title":"Awareness and understanding of cancer immunotherapy in Europe","volume":"10","author":"Mellstedt","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.bulcan.2026.07.014_bib0195","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1186\/s12885-020-06993-0","article-title":"Improving communication between the general practitioner and the oncologist: a key role in coordinating care for patients suffering from cancer","volume":"20","author":"Druel","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bulcan.2026.07.014_bib0200","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3917\/spub.252.0167","article-title":"D\u00e9mographie et activit\u00e9 de la population des m\u00e9decins g\u00e9n\u00e9ralistes rempla\u00e7ants en France en 2022","volume":"37","author":"Lorenzo-Kas","year":"2025","journal-title":"Sante Publ"},{"key":"10.1016\/j.bulcan.2026.07.014_bib0205","doi-asserted-by":"crossref","first-page":"e2327145","DOI":"10.1001\/jamanetworkopen.2023.27145","article-title":"Extended follow-up of chronic immune-related adverse events following adjuvant Anti\u2013PD-1\u00a0therapy for high-risk resected melanoma","volume":"6","author":"Goodman","year":"2023","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.bulcan.2026.07.014_bib0105","first-page":"921","article-title":"Usage and effectiveness of e-learning courses for continuous medical education","volume":"150","author":"Mazzoleni","year":"2009","journal-title":"Stud Health Technol Inform"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455126003887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455126003887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:26:42Z","timestamp":1793370402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455126003887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0007455126003887"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2026.07.014","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Connaissances des m\u00e9decins g\u00e9n\u00e9ralistes sur les immunoth\u00e9rapies anticanc\u00e9reuses et leurs effets ind\u00e9sirables\u00a0: une enqu\u00eate transversale","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2026.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}